The Belgium Journal
SEE OTHER BRANDS

The top news stories from Belgium

The Belgium Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Belgium Journal.

Press releases published on August 6, 2025

Jeremy Fields of Newsmatics Joins Forbes Communications Council

Jeremy Fields of Newsmatics Joins Forbes Communications Council

WASHINGTON , DC, UNITED STATES, August 6, 2025 /⁨EINPresswire.com⁩/ -- Jeremy Fields, vice president of corporate development at Newsmatics, has been accepted into the Forbes Communications Council, a prestigious, invitation-only organization made up of …

Michelman Expands Digital Printing Team to Support HP Indigo Customers

Michelman Expands Digital Printing Team to Support HP Indigo Customers

Three professionals added to Digital Printing team, furthering Michelman's mission to help press owners unleash the full potential of digital with HP Indigo. CINCINNATI, OH, UNITED STATES, August 6, 2025 /⁨EINPresswire.com⁩/ -- Michelman has added three …

DXRacer, pionnier mondial des chaises gaming, débarque en force au ChinaJoy 2025 – Hall E7, stand S507

DXRacer, pionnier mondial des chaises gaming, débarque en force au ChinaJoy 2025 – Hall E7, stand S507

PARIS, FRANCE, August 6, 2025 /⁨EINPresswire.com⁩/ -- DXRacer, marque emblématique du mobilier gaming, a récemment marqué les esprits lors du salon ChinaJoy 2025, qui s’est tenu du 1er au 4 août au Nouveau Centre International des Expositions de Shanghai. …

Galapagos NV kondigt aan dat GLPG5101 de status van Regenerative Medicine Advanced Therapy (RMAT) van de FDA krijgt voor de behandeling van recidief/refractair mantelcellymfoom

Galapagos NV kondigt aan dat GLPG5101 de status van Regenerative Medicine Advanced Therapy (RMAT) van de FDA krijgt voor de behandeling van recidief/refractair mantelcellymfoom

Mechelen, België; 6 augustus 2025, 7.30 uur CET; gereglementeerde informatie – voorwetenschap – Galapagos NV (Euronext …

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions